Ontrak (OTRK) Competitors $0.49 +0.01 (+1.04%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$0.48 -0.01 (-2.25%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OTRK vs. MGRX, SSY, BGLC, ACON, VSEE, ATIP, DHAC, NIVF, BACK, and BTTXShould you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), VSee Health (VSEE), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. Ontrak vs. Its Competitors Mangoceuticals SunLink Health Systems BioNexus Gene Lab Aclarion VSee Health ATI Physical Therapy Digital Health Acquisition NewGenIvf Group IMAC Better Therapeutics Ontrak (NASDAQ:OTRK) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment. Which has more risk and volatility, OTRK or MGRX? Ontrak has a beta of 2.16, suggesting that its share price is 116% more volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.4, suggesting that its share price is 140% more volatile than the S&P 500. Does the media prefer OTRK or MGRX? In the previous week, Ontrak had 1 more articles in the media than Mangoceuticals. MarketBeat recorded 2 mentions for Ontrak and 1 mentions for Mangoceuticals. Ontrak's average media sentiment score of 0.00 equaled Mangoceuticals'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ontrak 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mangoceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, OTRK or MGRX? Mangoceuticals has lower revenue, but higher earnings than Ontrak. Mangoceuticals is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOntrak$10.85M0.19-$25.49M-$15.81-0.03Mangoceuticals$511.08K15.63-$8.71M-$4.64-0.33 Is OTRK or MGRX more profitable? Ontrak has a net margin of -274.20% compared to Mangoceuticals' net margin of -2,191.76%. Mangoceuticals' return on equity of -72.81% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Ontrak-274.20% -269.88% -128.35% Mangoceuticals -2,191.76%-72.81%-66.58% Do analysts rate OTRK or MGRX? Ontrak currently has a consensus target price of $45.00, indicating a potential upside of 9,121.31%. Given Ontrak's stronger consensus rating and higher probable upside, equities research analysts plainly believe Ontrak is more favorable than Mangoceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Mangoceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in OTRK or MGRX? 13.0% of Ontrak shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 1.9% of Ontrak shares are owned by company insiders. Comparatively, 16.0% of Mangoceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryMangoceuticals beats Ontrak on 8 of the 15 factors compared between the two stocks. Get Ontrak News Delivered to You Automatically Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OTRK vs. The Competition Export to ExcelMetricOntrakMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.06M$3.91B$5.49B$9.01BDividend YieldN/A1.28%5.38%4.09%P/E Ratio-0.0335.6227.4220.26Price / Sales0.19101.05407.97121.21Price / CashN/A23.8136.6357.47Price / Book0.214.398.085.67Net Income-$25.49M$189.47M$3.16B$248.47M7 Day Performance-11.82%-1.09%2.81%3.29%1 Month Performance-66.80%-3.76%3.68%5.19%1 Year Performance-83.83%8.45%35.29%21.35% Ontrak Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OTRKOntrak2.7679 of 5 stars$0.49+1.0%$45.00+9,121.3%-83.9%$2.06M$10.85M-0.03250News CoverageGap UpHigh Trading VolumeMGRXMangoceuticals0.882 of 5 stars$1.52-12.1%N/A-97.8%$7.86M$620K-0.333News CoveragePositive NewsGap DownSSYSunLink Health SystemsN/A$0.88+0.6%N/A+16.6%$6.20M$31.09M6.291,376Positive NewsBGLCBioNexus Gene Lab0.3704 of 5 stars$3.07+10.8%N/A+33.5%$5.53M$9.51M0.0030Gap DownACONAclarion2.5567 of 5 stars$7.53+3.6%$11,758.50+156,055.4%-99.7%$4.37M$50K0.007News CoverageVSEEVSee Health1.2541 of 5 stars$1.16+5.5%$5.00+331.0%N/A$4.18MN/A0.00N/AGap UpATIPATI Physical Therapy0.2085 of 5 stars$0.90+4.7%N/A-80.8%$3.97M$741.86M-0.055,600Gap UpDHACDigital Health AcquisitionN/A$1.10-3.5%N/A-88.6%$3.96MN/A0.002,021Gap DownNIVFNewGenIvf GroupN/A$1.04+1.0%N/A-99.5%$543K$5.43M0.00N/APositive NewsHigh Trading VolumeBACKIMACN/A$0.05-23.3%N/A-97.0%$104K$72.05K0.00180BTTXBetter TherapeuticsN/A$0.00flatN/A-99.0%$5KN/A0.0040High Trading Volume Related Companies and Tools Related Companies MGRX Competitors SSY Competitors BGLC Competitors ACON Competitors VSEE Competitors ATIP Competitors DHAC Competitors NIVF Competitors BACK Competitors BTTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OTRK) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ontrak, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ontrak With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
